Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 25 04:00PM ET
4.33
Dollar change
-0.44
Percentage change
-9.22
%
Index- P/E- EPS (ttm)- Insider Own58.50% Shs Outstand47.90M Perf Week-20.11%
Market Cap207.41M Forward P/E- EPS next Y-2.44 Insider Trans5.52% Shs Float19.88M Perf Month-42.72%
Income- PEG- EPS next Q-0.46 Inst Own29.48% Short Float14.96% Perf Quarter-44.34%
Sales- P/S- EPS this Y95.61% Inst Trans- Short Ratio15.18 Perf Half Y-
Book/sh1.76 P/B2.46 EPS next Y-22.86% ROA- Short Interest2.97M Perf Year-
Cash/sh2.54 P/C1.70 EPS next 5Y- ROE- 52W Range3.98 - 14.50 Perf YTD-66.30%
Dividend Est.- P/FCF- EPS past 5Y-126.07% ROI- 52W High-70.14% Beta-
Dividend TTM- Quick Ratio9.37 Sales past 5Y0.00% Gross Margin- 52W Low8.79% ATR (14)0.57
Dividend Ex-Date- Current Ratio9.38 EPS Y/Y TTM- Oper. Margin- RSI (14)29.45 Volatility14.35% 9.80%
Employees- Debt/Eq0.72 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price20.00
Option/ShortNo / Yes LT Debt/Eq0.68 EPS Q/Q66.90% Payout- Rel Volume1.53 Prev Close4.77
Sales Surprise- EPS Surprise100.00% Sales Q/Q- EarningsMay 13 AMC Avg Volume195.98K Price4.33
SMA20-29.27% SMA50-32.90% SMA200-40.76% Trades Volume300,784 Change-9.22%
Date Action Analyst Rating Change Price Target Change
Feb-28-24Initiated Evercore ISI Outperform
Feb-27-24Initiated Morgan Stanley Overweight $18
Feb-27-24Initiated BofA Securities Buy $26
Jun-25-24 09:02AM
07:00AM
Jun-24-24 06:00AM
Jun-23-24 01:30PM
May-29-24 07:00AM
06:00AM Loading…
May-20-24 06:00AM
May-13-24 08:56PM
04:00PM
11:41AM
06:00AM
May-08-24 06:00AM
May-07-24 06:00AM
Apr-30-24 08:38AM
Apr-17-24 03:10PM
Apr-02-24 08:00AM
07:00AM Loading…
Apr-01-24 07:00AM
06:00AM
Mar-12-24 02:06PM
08:38AM
Mar-03-24 01:13PM
Feb-20-24 08:38AM
Feb-01-24 08:08PM
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elia MarcDirectorFeb 06 '24Buy15.00466,6666,999,9901,856,117Feb 08 04:32 PM
CVF, LLC10% OwnerFeb 06 '24Buy15.00333,3334,999,9954,673,870Feb 06 08:39 PM
Mithril LP10% OwnerFeb 06 '24Buy15.00333,3334,999,9951,251,900Feb 08 04:35 PM
Royan AjayDirectorFeb 06 '24Buy15.00333,3334,999,9951,251,900Feb 08 04:37 PM